Vancomycin (as HCl) 500mg/vial, 1g/vial; lyophilized pwd for IV infusion after reconstitution and dilution. Not for prophylaxis of endophthalmitis. Renal insufficiency. Monitor hearing, blood, renal ...

Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces the launch of the first-of-its-kind, ready-to-use vancomycin premix with room-temperature stability under ...

Ready-to-infuse sepsis therapy marks new advancement in time-critical treatment LONDON, July 2, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today ...

The US Food and Drug Administration (FDA) is issuing a compounding risk warning against intraocular injections of vancomycin either alone or in combination with other drugs, in light of a new case of ...

Please provide your email address to receive an email when new articles are posted on . The FDA is warning against the use of prophylactic intraocular vancomycin formulations during cataract surgery ...

(RTTNews) - Hospira, Inc., affiliated to Pfizer Inc., is recalling one lot of Vancomycin Hydrochloride Injection, USP 1.5g/vial, citing the presence of visible glass particulates, the U.S. Food and ...

Please provide your email address to receive an email when new articles are posted on . Intraosseous vancomycin levels were minimally detected at the end of the procedure vs. IV vancomycin levels.

(RTTNews) - Glenmark Pharmaceuticals Inc., USA, affiliated to India-based Glenmark Pharmaceuticals Ltd., announced Tuesday the launch of Vancomycin Hydrochloride for Injection USP in single-dose vials ...

Vancomycin (Vanacin CP 500mg Injection) is a glycopeptide antibiotic, prescribed for serious bacterial infections, endocarditis and surgical prophylaxis in major procedures. It kills sensitive ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

LONDON, July 2, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announced the approval of a novel formulation of the first-of-its-kind, ready-to ...